Paid Clinical Trials in Dallas, TX

As of July 2026, 1,538 paid clinical trials are recruiting in Dallas, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 21, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,359 clinical trials

↓ Download CSV

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

for Hemophilia

Sites in Dallas +4 more locations

Sponsor: Sanofi

Sex: Male·Age: 1 - 11

Code: NCT07285460·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

for Chronic Lymphocytic Leukemia

Drug: Emavusertib

Sites in Dallas +5 more locations

Sponsor: Curis, Inc.

Sex: All·Age: 18+

Code: NCT07271667·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

for Refractory Melanoma

Sites in Dallas +6 more locations

Sponsor: Diakonos Oncology Corporation

Sex: All·Age: 18+

Code: NCT07288112·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women

for Depressive Symptoms

Sites in Dallas +2 more locations

Sponsor: BTL Industries Ltd.

Sex: Female·Age: 22 - 60

Code: NCT07413692·Recruiting·Listed Feb 2026

Apply to this trial

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

for Diffuse Cutaneous Systemic Sclerosis

Sites in Dallas +5 more locations

Sponsor: Mediar Therapeutics

Sex: All·Age: 18+

Code: NCT07287670·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

for Phenylketonuria

Sites in Dallas +2 more locations

Sponsor: Agios Pharmaceuticals, Inc.

Sex: All·Age: 18 - 69

Code: NCT07241234·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

for Geographic Atrophy (GA)

Drug: Pozelimab

Sites in Dallas, Austin +3 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 50+

Code: NCT07230834·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

for Non Small Cell Lung Cancer (NSCLC)

Sites in Dallas +1 more location

Sponsor: Integro Theranostics

Sex: All·Age: 18+

Code: NCT07276789·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

for Generalized Lipodystrophy

Sites in Dallas +1 more location

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 2+

Code: NCT07220785·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy

Drug: Nucresiran

Sites in Dallas +7 more locations

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18 - 85

Code: NCT07223203·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

for Stargardt Disease

Sites in Dallas, Bellaire +4 more locations

Sponsor: AAVantgarde Bio Srl

Sex: All·Age: 8 - 55

Code: NCT07161544·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome

for Alport Syndrome

Sites in Dallas +5 more locations

Sponsor: Bayer

Sex: All·Age: 18 - 45

Code: NCT07211685·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer (NSCLC)

Sites in Dallas +8 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07140016·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

for Cancer

Sites in Dallas +2 more locations

Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07317505·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

for Geographic Atrophy

Sites in Dallas, Abilene +3 more locations

Sponsor: AbbVie

Sex: All·Age: 50+

Code: NCT07160179·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

for Angelman Syndrome

Sites in Dallas, Austin +6 more locations

Sponsor: Ultragenyx Pharmaceutical Inc

Sex: All·Age: 1 - 64

Code: NCT07157254·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

for Geographic Atrophy Secondary to Age-related Macular Degeneration

Sites in Dallas +6 more locations

Sponsor: Complement Therapeutics

Sex: All·Age: 55+

Code: NCT07144137·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

for Congenital Adrenal Hyperplasia

Sites in Dallas +8 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT07144163·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

for Niemann-Pick Type C Disease

Sites in Dallas +4 more locations

Sponsor: Azafaros B.V.

Sex: All·Age: 4+

Code: NCT07082725·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

for Hormone Receptor-positive Breast Cancer

Sites in Dallas +5 more locations

Sponsor: Ellipses Pharma

Sex: Female·Age: 18+

Code: NCT05573126·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

for Familial Partial Lipodystrophy

Sites in Dallas +6 more locations

Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All·Age: 13+

Code: NCT06679270·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

for Diffuse Astrocytoma, IDH-Mutant

Sites in Dallas +6 more locations

Sponsor: Neonc Technologies, Inc.

Sex: All·Age: 18+

Code: NCT06047379·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

for Lung Neoplasm

Sites in Dallas +2 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06780098·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for Niemann-Pick Type C Disease

Sites in Dallas +4 more locations

Sponsor: Azafaros B.V.

Sex: All·Age: 4+

Code: NCT07054515·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Study of STP938 (Dencatistat) in Advanced Solid Tumours

for Solid Tumor

Sites in Dallas, San Antonio +1 more location

Sponsor: Step Pharma, SAS

Sex: All·Age: 18+

Code: NCT06297525·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

Radiation Free Study

for Aortic Aneurysm

Sites in Dallas +4 more locations

Sponsor: Philips Clinical & Medical Affairs Global

Sex: All·Age: 18+

Code: NCT06549348·Recruiting·Listed Aug 2024

Apply to this trial

SW-682 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Dallas, Houston +6 more locations

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All·Age: 18+

Code: NCT06251310·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

NEO100 and High-Grade Meningioma

for Residual, Progressive or Recurrent Grade II or III Meningioma

Sites in Dallas +4 more locations

Sponsor: Neonc Technologies, Inc.

Sex: All·Age: 12+

Code: NCT05023018·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

Infant Formula in Infants and Children With Cow's Milk Allergy

for Cow's Milk Allergy

Sites in Dallas +7 more locations

Sponsor: Abbott Nutrition

Sex: All·Age: 3 Months - 12

Code: NCT06456541·Recruiting·Listed Jun 2024

Apply to this trial

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

for Primary Photoreceptor Disease

Sites in Dallas +4 more locations

Sponsor: BlueRock Therapeutics

Sex: All·Age: 18+

Code: NCT06789445·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

for Cancer

Sites in Dallas, Richardson +4 more locations

Sponsor: Helio Genomics

Sex: All·Age: 18+

Code: NCT05181826·Recruiting·Listed Jan 2022

Apply to this trial

A Study of LY3867070 in Healthy Participants

for Healthy

Sites in Dallas +1 more location

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07021547·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

for Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Sites in Dallas, Houston +6 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT05765812·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Asciminib Roll-over Study

for Chronic Myelogenous Leukemia

Sites in Dallas, Houston +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 7 - 100

Code: NCT04877522·Phase 4·Recruiting·Listed May 2021

Apply to this trial

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

for Advanced Solid Tumor

Sites in Dallas +4 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT06833008·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

for Colorectal Cancer

Sites in Dallas, Houston +2 more locations

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT05464030·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for Breast Neoplasms

Sites in Dallas, Houston +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06797635·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma

for Advanced Unresectable Hepatocellular Carcinoma

Drug: Tremelimumab

Sites in Dallas, Fort Worth +2 more locations

Sponsor: Riboscience, LLC.

Sex: All·Age: 18+

Code: NCT07175441·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

for Coronary Artery Disease

Sites in Dallas, Kyle +7 more locations

Sponsor: Teleflex

Sex: All·Age: 18+

Code: NCT06779630·Recruiting·Listed Jan 2025

Apply to this trial

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

for ARB

Sites in Dallas +3 more locations

Sponsor: Opus Genetics, Inc

Sex: All·Age: 18+

Code: NCT07185256·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial